phase 3 retatrutide Diabetes Dialogue: Reduces Body Weight 28.7% in Trial Eli Lilly infiltrates anti-obesity market

TEE, total energy expenditure

Molecule of the Month: GLP-1 Receptor Agonists Popular and effective drugs for the treatment of obesity and diabetes Improving on a lizard toxin Small molecule mimics Exploring the Structure Compare how peptide-based and small molecule drugs bind to the GLP-1 receptor While peptide-based GLP-1 receptor agonists all bind to the GLP-1 receptor in similar ways, the small molecule orforglipron is much smaller with far fewer interactions

Van LooGBertrandMJM

But the early results are tantalizing

The key difference is that semaglutide reduces your appetite, so you may naturally eat a smaller portion or feel satisfied after half a banana instead of a whole one